ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,728Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 395

$827K Total Retail Price of All Prescriptions

Rank: 20 out of 395

1,466 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nevada
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 1,466 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 1,466 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 1,088 980 294 1 1
HYDROCODONE-ACETAMINOPHEN 1,058 771 211 S3 2 5
OMEPRAZOLE 921 852 236 3 6
SIMVASTATIN 873 783 250 4 2
LEVOTHYROXINE SODIUM 823 765 175 5 3
AMLODIPINE BESYLATE 697 650 194 6 4
LOSARTAN POTASSIUM 539 481 142 7 9
WARFARIN SODIUM 464 438 71 8 19
GABAPENTIN 455 322 108 9 12
ATENOLOL 407 388 116 10 15
ALPRAZOLAM 404 301 87 B 11 14
METFORMIN HCL 394 327 119 12 7
ZOLPIDEM TARTRATE 356 279 72 13 18
HYDROCHLOROTHIAZIDE 317 287 89 14 13
TAMSULOSIN HCL 314 293 79 15 24
FUROSEMIDE 281 276* 75 16 10
ATORVASTATIN CALCIUM 276 236 90 17 8
PRAVASTATIN SODIUM 260 231 65 18 16
CARVEDILOL 247 228 67 19 23
TIZANIDINE HCL 240 181 68 20 87
METOPROLOL TARTRATE 223 223 69 21 11
CITALOPRAM HBR 217 181 60 22 26
CLOPIDOGREL 208 192 53 23 21
VENTOLIN HFA 201 152 86 24 46
POTASSIUM CHLORIDE 192 162 55 25 22
TRAZODONE HCL 176 138 60 26 41
LOVASTATIN 171 166* 54 27 17
DONEPEZIL HCL 166 161* 44 28 36
METOPROLOL SUCCINATE 165 147 43 29 25
TRAMADOL HCL 164 130 63 30 30
GLIPIZIDE 161 143 41 31 32
FLUTICASONE PROPIONATE 160 131 73 32 28
CIPROFLOXACIN HCL 159 146 116 33 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 155 140 44 34 27
ALENDRONATE SODIUM 155 150* 45 34 20
RANITIDINE HCL 153 134 41 36 37
LOSARTAN-HYDROCHLOROTHIAZIDE 146 141* 33 37 34
OXYCODONE HCL-ACETAMINOPHEN 145 106 33 S2 38 48
ALLOPURINOL 144 139* 41 39 29
IBUPROFEN 143 107 48 40 59
NIFEDIPINE ER 137 124 33 41 94
GLIMEPIRIDE 135 118 40 42 40
GLIPIZIDE ER 134 118 34 43 85
TEMAZEPAM 129 107 38 B 44 33
POLYETHYLENE GLYCOL 3350 127 104 57 45 102
CARISOPRODOL 127 45 20 R 45 65
FLUOXETINE HCL 117 76 24 47 44
FINASTERIDE 112 107* 32 48 58
OXYCODONE HCL 110 74 33 S2 49 42
SPIRIVA 106 101* 39 50 47
HYDRALAZINE HCL 104 86 37 51 61
LANTUS SOLOSTAR 98 93* 31 52 64
ISOSORBIDE MONONITRATE ER 97 92* 28 53 74
FENOFIBRATE* 92 73 21 54 49
METFORMIN HCL ER 90 85* 23 55 62
LORAZEPAM 84 65 16 B 56 43
SERTRALINE HCL 84 64 24 56 31
TRIAMTERENE-HCTZ 83 78* 25 58 56
BD ULTRA-FINE PEN NEEDLE 82 66 27 59 84
OXYCODONE-ACETAMINOPHEN 78 46 26 S2 60 81
SYMBICORT 78 73* 19 60 98
TERAZOSIN HCL 77 72* 19 62 55
ADVAIR DISKUS 76 71* 18 63 50
AZITHROMYCIN 74 61 54 64 38
AMITRIPTYLINE HCL 70 52 15 R 65 86
PAROXETINE HCL 67 62* 16 66 69
QVAR 65 60* 21 67 118
PIOGLITAZONE HCL 64 59* 16 R 68 73
NAPROXEN 63 52 31 69 99
LANTUS 59 46 14 70 91
MORPHINE SULFATE ER 57 32 11 S2 71 57
CLONIDINE HCL 57 52* 18 71 60
PREDNISONE 56 45 21 73 67
DIGOX 55 50* 16 74 108
DILTIAZEM 24HR ER 50 50 17 75 121
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.